Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today introduced Invisalign Virtual Care AI, its next generation remote monitoring solution with new artificial intelligence-assisted capabilities that streamline workflows for doctors and their

Align Technology's Next Generation Invisalign Virtual Care AI-assisted Remote Monitoring Solution Automates and Streamlines Practice Workflows

Advanced Micro Devices

Bio-Rad Laboratories

Caesars Entertainment

DISH Network

Generac Holdings

MGM Resorts

News Corp

Bio-Techne

Warner Bros Discovery Inc

Analysts are either optimistic or delusional. But either way, they see a big S&P 500 29% rally coming — and have picked favorite stocks.

10 Stocks Are Screaming Buys As Monster Rally Nears, Analysts Say

Abbott Labs

Both companies are experts at tapping into sources of long-term growth in their markets.

Got $2,000? Invest In These 2 Perpetually Growing Stocks

TEMPE, Ariz. & WROCLAW, Poland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM services for orthodontic and restorative dentistry, today announced the official opening of the first Europe, Middle East & Africa (EMEA) regional manufacturing facility in Wroclaw, Poland. The new plant is Align's third regional

Align Technology Opens Its First EMEA Regional Manufacturing Facility in Wroclaw, Poland

Match Group

Netflix

A deeply discounted share price is only a bargain if the underlying company is worth owning.

Should You Buy the S&P 500's 3 Worst-Performing Stocks of 2022?

STAAR Surgical

Both companies are facing headwinds that will soon be a thing of the past.

2 Ravenously Growing Stocks to Buy and Hold No Matter What

Investors shrugged off a so-so second-quarter report.

Why Shares of Align Technology Rose 18.7% in July

The dull underlying market situation, impacted by macro-economic environmental factors and lingering effects of COVID-19 variants in certain markets, impacts Align Technology's (ALGN) Q2 results.

Align Technology (ALGN) Q2 Earnings Lag Estimates, Margins Drop

There's not much Align can do about either of its major headwinds.

These 2 Huge Headwinds Are Whomping Align Technology Stock

Align Technology (ALGN) delivered earnings and revenue surprises of -5.66% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Align Technology (ALGN) Q2 Earnings and Revenues Miss Estimates

Align Technology, Inc. (NASDAQ:ALGN ) Q2 2022 Earnings Conference Call July 27, 2022 4:30 PM ET Company Participants Shirley Stacy - Vice President-Corporate Communications & Investor Relations Joe Hogan - President & Chief Executive Officer John Morici - Chief Financial Officer Conference Call Participants Nathan Rich - Goldman Sachs Elizabeth Anderson - Evercore Jon Block - Stifel Jeff Johnson - Baird Jason Bednar - Piper Sandler Erin Wright - Morgan Stanley Brandon Couillard - Jefferies Kevin Caliendo - UBS Michael Ryskin - Bank of America Operator Greetings. Welcome to the Align Q2 2022 earnings call.

Align Technology, Inc. (ALGN) CEO Joe Hogan on Q2 2022 Results - Earnings Call Transcript

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter of fiscal 2022 ("Q2'22"). Q2'22 total revenues were $969.6 million, down 0.4% sequentially and down 4.1% year-over-year. Q2'22 Clear Aligner reve

Align Technology Announces Second Quarter 2022 Financial Results

Boston Scientific

Hologic

MedTech companies' results are likely to reflect a rebound in the base business. Let's see how BSX, HOLX and ALGN fare this time.

MedTech Stocks' Earnings Due on Jul 27: BSX, HOLX & ALGN

Align Technology is getting slammed by problems outside its control, but things are slated to improve.

Got $5,000? This Punished Growth Stock Won't Be Cheap Forever

Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Align Technology (ALGN) Q2 Earnings Expected to Decline

Mastercard

NVIDIA

These stocks are all trading near their 52-week lows.

Bear Market Buys: Where to Invest $5,000 Right Now

Chevron

Johnson & Johnson

QUALCOMM

Exxon Mobil

A number of S&P 500 stocks offer a compelling buying opportunity for investors with a long-term mindset. The post 7 Best S&P 500 Stocks to Buy in July appeared first on InvestorPlace.

7 Best S&P 500 Stocks to Buy in July

DexCom

Intuitive Surgical

Even after losing nearly 65% of its market value in the first half of the year, Align Technology Inc. ( ALGN , Financial) still does not look like anything approaching a buy. The Phoenix-area company earned the dubious distinction of leading the steep decline among medical device providers in the first six months of 2022, according to health care consulting firm Evaluate.

Investors Wise to Steer Clear of Medtechs Providing Self-Pay Products, Services

Becton, Dickinson and Co.

BDX vs. ALGN: Which Stock Is the Better Value Option?

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2022 financial results on Wednesday, July 27, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and wi

Align Technology to Announce Second Quarter 2022 Results on July 27, 2022

Bath and Body Works

Carnival

Ceridian HCM Holding Inc.

EPAM Systems

Etsy

PayPal

Royal Caribbean Cruises

Concerns about high inflation, aggressive rate hikes by the Federal Reserve, and the potential for an economic recession jolted investor sentiment.

These were the 10 worst performing stocks in the S&P 500 in its worst half since 1970

These stocks are down by 60% or more this year -- but are they long-term buys?

Should You Buy the S&P 500's 5 Worst-Performing 2022 Stocks?

These stocks have taken a beating this year but their growth potential remains promising.

2 of the Best Nasdaq Stocks to Buy for July

Align Technology's (ALGN) focus on expanding its global operations, both in existing and emerging international markets, raises optimism.

Align (ALGN) Gains From Increased Case Shipment Amid FX Woes

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry today announced a $250 thousand donation to JA (Junior Achievement) Worldwide through the Align Foundation, the Company's donor-advised charitable fund through Fidelity Charitable. The donation

Align™ Technology Celebrates Its 25th Anniversary With US$250,000 Contribution to JA Worldwide Through the Align Foundation to Support Both Organizations' Shared Purpose of Inspiring and Preparing Young People to Succeed

News for Align Technology Stock (ALGN)